Peri-operative management of carcinoid syndrome using ketanserin.
This report describes the successful use of ketanserin, a 5-HT2 receptor antagonist, for the acute control of systemic blood pressure in a patient with the carcinoid syndrome, undergoing hepatic artery embolisation. Serial measurements of plasma 5-hydroxyindoles, platelet 5-hydroxytryptamine and plasma catecholamines are also given.
D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004621:Embolization, Therapeutic; D005260:Female; D006499:Hepatic Artery; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007432:Intraoperative Period; D007650:Ketanserin; D008303:Malignant Carcinoid Syndrome / Q000503:physiopathology / Q000628:therapy*; D010880:Piperidines / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D010880:Piperidines; D007650:Ketanserin